# Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures

> **NCT00154141** · PHASE3 · COMPLETED · sponsor: **Ethicon, Inc.** · enrollment: 150 (—)

## Conditions studied

- Peripheral Vascular Disease

## Interventions

- **DRUG:** Fibrin sealant (FS2)

## Key facts

- **NCT ID:** NCT00154141
- **Lead sponsor:** Ethicon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 150 (—)
- **Last updated:** 2006-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154141, "Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00154141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*